Giant Cell Arteritis

‘Slope sign’: a feature of large vessel vasculitis?
Bhaskar Dasgupta, Kate Smith, Abdullah Abu Syeed Khan, Fiona Coath, Richard J Wakefield

Annals of the Rheumatic Diseases Dec 2019, 78 (12) 1738; DOI: 10.1136/annrheumdis-2019-216213
Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?
Gerasimos Evangelatos, George E Fragoulis, Alexios Iliopoulos

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-216527; DOI: 10.1136/annrheumdis-2019-216527
Clinical symptoms and associated vascular imaging findings in Takayasu’s arteritis compared to giant cell arteritis
Despina Michailidou, Joel S Rosenblum, Casey A Rimland, Jamie Marko, Mark A Ahlman, Peter C Grayson

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216145; DOI: 10.1136/annrheumdis-2019-216145
Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study
Carlotta Nannini, Laura Niccoli, Stelvio Sestini, Iashar Laghai, Angela Coppola, Fabrizio Cantini

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1444-1446; DOI: 10.1136/annrheumdis-2019-215585
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Bernhard Hellmich, Ana Agueda, Sara Monti, Frank Buttgereit, Hubert de Boysson, Elisabeth Brouwer, Rebecca Cassie, Maria C Cid, Bhaskar Dasgupta, Christian Dejaco, Gulen Hatemi, Nicole Hollinger, Alfred Mahr, Susan P Mollan, Chetan Mukhtyar, Cristina Ponte, Carlo Salvarani, Rajappa Sivakumar, Xinping Tian, Gunnar Tomasson, Carl Turesson, Wolfgang Schmidt, Peter M Villiger, Richard Watts, Chris Young, Raashid Ahmed Luqmani

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215672; DOI: 10.1136/annrheumdis-2019-215672
Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses
Christoph T Berger, Birke Rebholz-Chaves, Mike Recher, Tobias Manigold, Thomas Daikeler

Annals of the Rheumatic Diseases Jul 2019, 78 (7) 1012-1014; DOI: 10.1136/annrheumdis-2018-214704
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al
Christoph T Berger, Thomas Daikeler

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215729; DOI: 10.1136/annrheumdis-2019-215729
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone
Maxime Samson, Bernard Bonnotte

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215697; DOI: 10.1136/annrheumdis-2019-215697
The role of temporal artery biopsy in patients with giant-cell arteritis is debated
Sergey V Moiseev, Ilya Smitienko, Nikolay Bulanov, Pavel I Novikov

Annals of the Rheumatic Diseases Apr 2019, 78 (4) e31; DOI: 10.1136/annrheumdis-2018-213282
Response to: ‘The role of temporal artery biopsy in patients with giant cell arteritis is debated’ by Moiseev et al
Christian Dejaco, Sofia Ramiro, Christina Duftner, Wolfgang A Schmidt

Annals of the Rheumatic Diseases Apr 2019, 78 (4) e32; DOI: 10.1136/annrheumdis-2018-213284

Main menu

Giant Cell Arteritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Giant Cell Arteritis

Pages